Visionary News & Insightful Strategy
Ip MS. Update on the current treatment of diabetic retinopathy. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.
Disclosures:
Ip reports consulting for Alimera Sciences, Allergan, Amgen, Apellis, Biogen, Cell Lineage, Clearside Biomedical, Genentech, Iveric Biour, Novartis, OccuRx, ONL Therapeutics, Regeneron and Regenxbio.
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Leave a Reply